INFECCION POR SARS COV-2

ISBN: 978-84-09-36359-9

AUTORES

Patricia Pérez Guerrero
Concepción Collado Pérez
Desirée V. Gerez Neira



BIBLIOGRAFÍA

  • Ramakrishnan S, Nicolau DV Jr, Langford B, et al. Inhaled budesonide in the treatment of early COVID (STOIC): a phase 2, open-label, randomized controlled trial. Lancet 2021.
  • The RECOVERY Collaborative. Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report. N Engl J Med. 2020 Jul 17;1–11.
  • Pulakurthi YS, Pederson JM, Saravu K, Gupta N, Balasubramanian P, Kamrowski S, Schmidt M, Vegivinti CTR, Dibas M, Reierson NL, Pisipati S, Joseph BA, Selvan PT, Dmytriw AA, Keesari PR, Sriram V, Chittajallu S, Brinjikji W, Katamreddy RR, Chibbar R, Davis AR, Malpe M, Mishra HK, Kallmes KM, Hassan AE, Evanson KW. Corticosteroid therapy for COVID-19: A systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore). 2021 May 21;100(20):e25719.
  • Callejas Rubio JL, Luna del Castillo J de D, de la Hera Fernández J, Guirao Arrabal E, Colmenero Ruiz M, Ortego Centeno N. Effectiveness of corticoid pulses in patients with cytokine storm syndrome induced by SARS-CoV-2 infection. Med Clin (Barc). 2020 Aug 28;155(4):159–61.
  • Wang Y, Zhang D, Du G, Du R, Zhao J, Jin Y, et al. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2020 May 16;395(10236):1569–78.
  • Xie Y, Cao S, Dong H, Li Q, Chen E, Zhang W, Yang L, Fu S, Wang R. Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19. J Infect. 2020 Aug;81(2):318-356.
  • Kalil AC, Patterson TF, Metha AK, et al. Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19. N Engl J Med. 2021; 384:795-807
  • Stebbing J, Sánchez Nievas G, Falcone M, Youhanna S, Richardson P, Ottaviani S, et al. JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality. Sci Adv. 2020 Nov 13:eabe4724.
  • Salvarani C, Dolci G, Massari M, Merlo DF, Cavuto S, Savoldi L, et al; RCT-TCZ-COVID-19 Study Group. Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial. JAMA Intern Med. 2020 Oct 20:e206615.
  • Huet T, Beaussier H, Voisin O, Jouveshomme S, Dauriat G, Lazareth I, et al. Anakinra for severe forms of COVID-19: a cohort study. Lancet Rheumatol. 2020 Jul 1;2(7):e393–400.
  • Protocolo coronavirus (covid-19) y Gestacion (V13 8/03/21). En protoclos de Medicina MaternofetalHospital Clinic. Universidad de Barcelona
  • Mensa J, Soriano A, Marco F et al. Coronavirus SARS-Cov-2 (COVID-19). En: Guia Mensa de Terapéutica Antimicrobiana. Actualizacion 19 Jul 2021